Cairn Terrier Supplements

Cairn Terriers are a hardy working terrier breed with a spirited personality and a specific set of health vulnerabilities. Most critically, Cairns have elevated rates of portosystemic shunts (liver shunts) — a congenital condition where blood bypasses the liver. This directly affects which supplements are safe, since the liver processes many nutrients and supplement metabolites. Cairns with liver shunts require veterinary guidance on supplementation.

Primary health vulnerabilities in Cairn Terriers

• Portosystemic shunts (liver shunts): Cairn Terriers have one of the highest portosystemic shunt rates of small breeds. Liver shunts cause hepatic encephalopathy, stunted growth, and hypoglycemia. Critical supplement caution: avoid high-protein supplements and amino acid concentrates (including high-dose L-carnitine, L-glutamine, or taurine supplements) in shunt-affected dogs — excess ammonia production worsens encephalopathy. Always diagnose shunt status before high-dose supplementation.
• Allergic skin disease: Environmental atopy causing paw licking, skin redness, and ear infections is common in Cairns. Their dense double coat masks early skin inflammation.
• Globoid cell leukodystrophy (Krabbe disease): Rare but severe neurological condition seen in Cairn Terriers. DNA testing is available through breed health organizations.

Cairn Terrier supplement stack — liver shunt aware

• Omega-3 (EPA+DHA): For a 13–18 lb Cairn: ~250–400mg EPA+DHA daily. Safe in shunt-affected dogs at standard doses. Reduces allergic inflammatory burden without hepatic metabolism concerns.
• Quercetin + bromelain: Small-breed doses. Mast cell stabilization for atopic skin disease. No significant hepatic processing concerns at standard doses.
• Probiotics: Gut-immune calibration. Use bacterial-strain probiotics; avoid yeast-containing probiotics in shunt-affected dogs.